AI
The software automatically analyses chest CT images for pneumonia.
The Dubai-based GluCare Integrated Diabetes Center has published a second set of clinical results revealing further reduction of haemoglobin A1c (HbA1c) levels in its patients.
The partnership will initially be used to distribute PathAI’s research-use-only algorithm focusing on immuno-oncology.
Also, US-based Pearl has received regulatory approvals to market its AI diagnostic tool for dental radiology in Australia and New Zealand.
Clinical research is set to verify the technology's effectiveness in estimating abnormal heart movements.
The AI medical station can generate an automated diagnosis that remote care providers can access to confirm.
The tool is also able to check the lung condition of COVID-19 patients.
The AI solution automatically analyses cardiac CT scans and produces reports within 15 minutes.
This collaboration will work with an unnamed pharma company in Japan to know how its drugs behave compared to rival products.
The startup has developed an AI support tool that detects COVID-19 patterns from chest x-ray images.